Page 14 - Devices Agency News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Longeveron Receives Notice of United States Patent Allowance for the Technology Behind its Lead Investigation Product Lomecel-B™

MIAMI, Jan. 29, 2024 (GLOBE NEWSWIRE) Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company deve.

United statesMike moyerTrademark officeLongeveron or companyExchange commission onJapan pharmaceuticalsLongeveron incDevices agencyEuropean unionExchange commissionUnited states patentMedicinal signaling cellsAging related frailtyMedical devices agencyRegenerative medicineChief scientific officer

Travere signs $120m licensing deal with Renalys for sparsentan in Asia

Renalys plans to start a registrational trial for sparsentan as a treatment for IgA nephropathy in Japan in Q2 2024.

Republic ofSouth koreaCatalys pacificRenalys pharmaSmartphotolab shutterstockDevices agencyCompany profileCompany profilesDrug administrationJapanese pharmaceuticalsJapan based renalys pharmaMedical devices agency

Eisai Submits New Drug Application for Mecobalamin Ultrahigh-Dose Formulation in Japan for the Indication of Amyotrophic Lateral Sclerosis

Eisai Submits New Drug Application for Mecobalamin Ultrahigh-Dose Formulation in Japan for the Indication of Amyotrophic Lateral Sclerosis
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Stefan klotterEisai co ltdTokushima universityDevices agencyTokushima university graduate school of biomedical sciencesMinistry of healthDepartment of neurologyPublic relations departmentChiba university graduate school of medicineWelfare specified disease treatment research programNew drug applicationMedical devices agencyJapan early stage trialUltrahigh dose methylcobalaminExtraordinary professor ryuji kajiPrincipal investigator

acnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acnnewswire.com Daily Mail and Mail on Sunday newspapers.

Eisai co ltdPublic relations departmentMinistry of healthDevices agencyWelfare specified disease treatment research programTokushima university graduate school of biomedical sciencesChiba university graduate school of medicineDepartment of neurologyTokushima universitySubmits new drug applicationMecobalamin ultrahigh dose formulationAmyotrophic lateralNew drug applicationMedical devices agencyJapan early stage trialUltrahigh dose methylcobalamin

Renalys Pharma Is Launched To Bring New Innovative Medicines To Patients In Japan and Other Countries In Asia

/PRNewswire/ Catalys Pacific, a transpacific life science investment firm, and SR One, a transatlantic life sciences investment firm, today announced the.

United statesSan franciscoChuo kuRenalys pharmaAculys pharmaCatalys pacificPrnewswire catalys pacificPathalys pharmaDevices agencyRenalys pharma incTravere therapeuticsMedical devices agencyManaging directorKyowa kirinMineralys therapeutics